CIBC Bancorp USA’s Bio-Techne TECH Stock Holding History

CIBC Bancorp USA’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.55M	Sell	64,401 -1,938	-3%	-$105K	0.01%	782
2026 Q1	$3.47M	Buy	+66,339	New	+$3.98M	﹤0.01%	799
2025 Q3	$890K	Buy	+16,007	New	+$857K	﹤0.01%	702

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return

CIBC Bancorp USA's TECH Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Bio-Techne (TECH) stake by 2.9% in Q2 2026, selling an estimated $105K and leaving 64,401 shares worth $4.55M. The position accounts for 0.01% of the portfolio, ranked #782.

CIBC Bancorp USA first reported a position in TECH in Q3 2025 and has held it in 3 quarters since. 560 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

CIBC Bancorp USA held 64,401 shares of Bio-Techne worth $4.55M as of Q2 2026.
CIBC Bancorp USA sold 1,938 Bio-Techne shares in Q2 2026, an estimated $105K.
Bio-Techne made up 0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #782 holding.
CIBC Bancorp USA first reported a position in Bio-Techne in Q3 2025 and has held it in 3 quarters since.
560 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.